RS-56812

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRS-56812
Drug Alias NameRS-56812
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Palo Alto Llc
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A